Month: August 2021

Proper stretches before and after a run can improve your performance and decrease your risk of injury. Dusty Marie Narducci, M.D., Sports Medicine Fellow, discusses the importance of stretching and offers demonstrations of several dynamic and static stretches.
0 Comments
Treatment for Prevention of COVID-19 Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of Comirnaty in Individuals 16 and Older New Phase 3 data show booster (third) dose of Comirnaty induces significant SARS-CoV-2 neutralizing antibody titers and demonstrated a favorable safety and tolerability profile SARS-CoV-2 neutralizing
0 Comments
ATLANTA, Aug. 30, 2021 /PRNewswire/ — UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact (brivaracetam) CV tablets, oral solution, and injection to treat partial-onset seizures in patients as young as one month of age.2 This is the first time that the IV formulation of Briviact
0 Comments
What is it that makes a simple jigsaw puzzle such an effective mindfulness practice? It’s the rainy day classic that became a lockdown essential, and while there’s nothing new about puzzles (the first jigsaw is thought to have been created in 1762), many of us are just starting to realise the potentially mindful boost that
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients on immunosuppressive or immunomodulatory therapy should receive a third dose of either the Pfizer-BioNTech COVID-19 vaccine or the Moderna COVID-19 vaccine at least 28 days after the second dose of either of these two mRNA vaccines, according to updated recommendations
0 Comments
Taiwan is banking on a homegrown Covid-19 shot to speed up its inoculation program as the island and many countries struggle to secure vaccine deliveries from major drug companies. The locally produced Covid vaccine from Medigen Vaccine Biologics was rolled out last week, with President Tsai Ing-wen receiving her first shot of the two-dose vaccine
0 Comments
Since the COVID-19 pandemic reached the United States in early 2020, scientists have struggled to find laboratory models of SARS-CoV-2 infection, the respiratory virus that causes COVID-19. Animal models fell short; attempts to grow adult human lungs have historically failed because not all of the cell types survived. Undaunted, stem cell scientists, cell biologists, infectious
0 Comments
A new study from the Prevention Research Center of the Pacific Institute for Research and Evaluation finds that recreational marijuana legalization may increase the risk of alcohol and marijuana co-use among adolescents. The study examined the association between recreational marijuana legalization in California in November 2016 and alcohol and marijuana co-use among underage youth. The
0 Comments
Public health authorities have been persuading the general masses to get the COVID-19 booster shots once they have become available. But the guidance has mostly been for those who received the mRNA vaccines from Pfizer and Moderna, leaving recipients of Johnson & Johnson’s Janssen vaccine wondering if they also need the additional dose of the vaccine. 
0 Comments
As we get older, it’s more and more likely that more of us will live alone.  According to the latest information from the Merck Manuals, some 28% (14.7 million) of US community-dwelling older adults live alone (21% of older men and 34% of older women). The numbers increase with age – some 44 percent of
0 Comments
elamipretide Treatment for Barth Syndrome Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome BOSTON, Aug. 24, 2021 /PRNewswire/ – Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced the submission of a New Drug Application (NDA)
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE) August 20, 2021 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the adjuvant treatment of patients with urothelial carcinoma (UC) who are at
0 Comments
A new noninvasive procedure is safe and effective for treating patients with mild Alzheimer’s disease (AD), new research suggests. The approach uses MRI-guided low-intensity focused ultrasound (FUS) and injected microbubbles to temporarily open the blood-brain barrier (BBB). In a small group of patients, the procedure was significantly associated with reduced amyloid plaque and cognitive decline.
0 Comments
An Israeli man receives a third shot of coronavirus disease (COVID-19) vaccine as country launches booster shots for over 30-year-olds, in Rishon Lezion, Israel August 24, 2021. Nir Elias | Reuters Israeli lawmakers are keen to avoid another lockdown after overseeing one of the world’s fastest vaccination drives. New daily coronavirus infections, however, have just
0 Comments
Finerenone (Kerendia) prevents cardiovascular (CV) and some renal events in type 2 diabetes patients with earlier stages of kidney disease, the FIGARO-DKD trial showed. In the trial’s stage 1 to 4 kidney disease patients with moderate-to-severe albuminuria, the nonsteroidal mineralocorticoid receptor antagonist (MRA) reduced the composite of CV death, nonfatal myocardial infarction or stroke, or
0 Comments
ABBOTT PARK, Ill., Aug. 27, 2021.  Abbott today announced results of the landmark GUIDE-HF clinical trial, a 1,000 patient randomized study designed to assess the benefits of the CardioMEMS HF System in people living with NYHA Class II, III and IV heart failure. Data adjusted for the impact of COVID-19 show a strong reduction in
0 Comments
Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of non-standard therapies should be strongly discouraged, according to a study of their effectiveness by a Weill Cornell Medicine and NewYork-Presbyterian investigator and collaborating colleagues in the Pediatric Epilepsy Research Consortium. Early treatment
0 Comments
In patients with coronary artery disease scheduled for a percutaneous intervention (PCI), fractional flow reserve (FFR) assessment at the time of angiography significantly improves outcome, but it has no apparent value as a routine study in all CAD patients, according to the randomized RIPCORD 2 trial. When compared to angiography alone in an all comer-strategy,
0 Comments
Family bonds often run the deepest, which is why it’s all the more painful when they break down. Here, with the help of a counsellor, we explore how to navigate difficult family relationships Families: they’re not always easy. Separation, blended households, addictions, mental illness, money problems, betrayal, expectations, communication, or simply clashing personalities – there
0 Comments
The addition of image-guided atrial fibrosis ablation did not significantly reduce the risk of recurrence relative to pulmonary vein isolation (PVI) alone in patients with treatment-resistant atrial fibrillation (AFib), according to results of an intention-to-treat analysis of the randomized DECAAF II trial. However, there was a significant advantage for the addition of image-guided ablation in
0 Comments
Elizabeth Holmes, founder and former CEO of Theranos, arrives for motion hearing on Monday, Nov. 4, 2019, at the U.S. District Court House inside Robert F. Peckham Federal Building in San Jose, California. Yichuan Cao | NurPhoto | Getty Images In a bombshell revelation just days before her criminal fraud trial, defense attorneys for Elizabeth
0 Comments
His bundle pacing has now entered guidelines from the European Society of Cardiology (ESC). The update to the cardiac pacing and cardiac resynchronization therapy (CRT) guidelines also brought changes on pacing after syncope or transcatheter aortic valve implantation (TAVI), as well as revisions to recommendations on loop recorders, CRT in heart failure, and implantable device
0 Comments
Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a
0 Comments